An Inception Cohort Study Assessing the Role of Pneumococcal and other Bacterial Pathogens in Children with Influenza and ILI and a Clinical Decision Model for Stringent Antibiotic Use
- 1 July 2015
- journal article
- research article
- Published by SAGE Publications in Antiviral Therapy
- Vol. 21 (5) , 413-424
Abstract
Background: Influenza-like illness (ILI) is a common reason for paediatric consultations. Viral causes predominate, but antibiotics are used frequently. With regard to influenza, pneumococcal coinfections are considered major contributors to morbidity/mortality. Methods: In the context of a perennial quality management (QM) programme at the Charité Departments of Paediatrics and Microbiology in collaboration with the Robert Koch Institute, children aged 0–18 years presenting with signs and symptoms of ILI were followed from the time of initial presentation until hospital discharge (Charité Influenza-Like Disease = ChILD Cohort). An independent QM team performed highly standardized clinical assessments using a disease severity score based on World Health Organization criteria for uncomplicated and complicated/progressive disease. Nasopharyngeal and pharyngeal samples were collected for viral reverse transcription polymerase chain reaction and bacterial culture/sensitivity and MaldiTOF analyses. The term ‘detection’ was used to denote any evidence of viral or bacterial pathogens in the (naso)pharyngeal cavity. With the ChILD Cohort data collected, a standard operating procedure (SOP) was created as a model system to reduce the inappropriate use of antibiotics in children with ILI. Monte Carlo simulations were performed to assess cost-effectiveness. Results: Among 2,569 ChILD Cohort patients enrolled from 12/2010 to 04/2013 (55% male, mean age 3.2 years, range 0–18, 19% >5 years), 411 patients showed laboratory-confirmed influenza, with bacterial co-detection in 35%. Influenza and pneumococcus were detected simultaneously in 12/2,569 patients, with disease severity clearly below average. Pneumococcal vaccination rates were close to 90%. Nonetheless, every fifth patient was already on antibiotics upon presentation; new antibiotic prescriptions were issued in an additional 20%. Simulation of the model SOP in the same dataset revealed that the proposed decision model could have reduced the inappropriate use of antibiotics significantly ( P≤0.01) with an incremental cost-effectiveness ratio of -99.55€. Conclusions: Physicians should be made aware that in times of pneumococcal vaccination the prevalence and severity of influenza infections complicated by pneumococci may decline. Microbiological testing in combination with standardized disease severity assessments and review of vaccination records could be cost-effective, as well as promoting stringent use of antibiotics and a personalized approach to managing children with ILI.Keywords
This publication has 53 references indexed in Scilit:
- Prevention of pneumococcal diseases in the post-seven valent vaccine era: A European perspectiveBMC Infectious Diseases, 2012
- Predictors of clinical outcome in a national hospitalised cohort across both waves of the influenza A/H1N1 pandemic 2009–2010 in the UKThorax, 2012
- Severe influenza cases in paediatric intensive care units in Germany during the pre-pandemic seasons 2005 to 2008BMC Infectious Diseases, 2011
- Use and feasibility of delayed prescribing for respiratory tract infections: A questionnaire surveyBMC Family Practice, 2011
- Viral Infections of the Lower Respiratory Tract: Old Viruses, New Viruses, and the Role of DiagnosisClinical Infectious Diseases, 2011
- Respiratory Viral Infections in Infants: Causes, Clinical Symptoms, Virology, and ImmunologyClinical Microbiology Reviews, 2010
- Genetic Variability of Group A Human Respiratory Syncytial Virus Strains Circulating in Germany from 1998 to 2007Journal of Clinical Microbiology, 2009
- Predominant Role of Bacterial Pneumonia as a Cause of Death in Pandemic Influenza: Implications for Pandemic Influenza PreparednessThe Journal of Infectious Diseases, 2008
- Viral Upper Respiratory Tract Infection and Otitis Media Complication in Young ChildrenClinical Infectious Diseases, 2008
- Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studiesBMJ, 2007